clinical trial · NCT05618314
Study of AT-527 in Subjects With Normal and Impaired Renal Function
Healthy VolunteerRenal ImpairmentAT-527AT-527AT-527 and Probenecid
brief summary
Study of AT-527 in Subjects with Normal and Impaired Renal Function
started
Oct 17, 2022
primary completion
Jun 15, 2024
completion
Jun 15, 2024
last updated
Jul 31, 2024
official title
A Phase 1, Open-Label, Parallel-Group, Single-Dose Adaptive Study to Evaluate the Safety and Pharmacokinetics of AT-527 in Adult Subjects With Normal and Impaired Renal Function Sub-Study: Effects of Probenecid on the Pharmacokinetics of AT-527 in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol